International Registry of Patients Carrying TGFBR1 or TGFBR2 Mutations
Circulation: Cardiovascular Genetics · 2016-12 · 9 (6) · 548-558
DOI: 10.1161/circgenetics.116.001485 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Circulation: Cardiovascular Genetics, 2016-12. Verfasst von Guillaume Jondeau und 28 weiteren Autor:innen. Hauptthemen laut MEDLINE: Aorta, Thoracic, Heterozygote, Mutation. Die Arbeit wurde bisher 198-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Background— The natural history of aortic diseases in patients with TGFBR1 or TGFBR2 mutations reported by different investigators has varied greatly. In particular, the current recommendations for the timing of surgical repair of the aortic root aneurysms may be overly aggressive. Methods and Results— The Montalcino Aortic Consortium, which includes 15 centers worldwide that specialize in heritable thoracic aortic diseases, was used to gather data on 441 patients from 228 families, with 176 cases harboring a mutation in TGBR1 and 265 in TGFBR2 . Patients harboring a TGFBR1 mutation have similar survival rates (80% survival at 60 years), aortic risk (23% aortic dissection and 18% preventive aortic surgery), and prevalence of extra-aortic features (29% hypertelorism, 53% cervical arterial tortuosity, and 27% wide scars) when compared with patients harboring a TGFBR2 mutation. However, TGFBR1 males had a greater aortic risk than females, whereas TGFBR2 males and females had a similar aortic risk. Additionally, aortic root diameter prior to or at the time of type A aortic dissection tended to be smaller in patients carrying a TGFBR2 mutation and was ≤45 mm in 6 women with TGFBR2 mutations, presenting with marked systemic features and low body surface area. Aortic dissection was observed in 1.6% of pregnancies. Conclusions— Patients with TGFBR1 or TGFBR2 mutations show the same prevalence of systemic features and the same global survival. Preventive aortic surgery at a diameter of 45 mm, lowered toward 40 in females with low body surface area, TGFBR2 mutation, and severe extra-aortic features may be considered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Förderung
- NHLBI NIH HHS
Zitieren
APA
Jondeau, G., Ropers, J., Regalado, E., Braverman, A., Evangelista, A., Teixedo, G., De Backer, J., Muiño-Mosquera, L., Naudion, S., Zordan, C., Morisaki, T., Morisaki, H., Von Kodolitsch, Y., Dupuis-Girod, S., Morris, S. A., Jeremy, R., Odent, S., Adès, L. C., Bakshi, M., …, & Montalcino Aortic Consortium (2016). International Registry of Patients Carrying TGFBR1 or TGFBR2 Mutations. Circulation: Cardiovascular Genetics, 9(6), 548-558. https://doi.org/10.1161/circgenetics.116.001485
Vancouver
Jondeau G, Ropers J, Regalado E, Braverman A, Evangelista A, Teixedo G, et al. International Registry of Patients Carrying TGFBR1 or TGFBR2 Mutations. Circulation: Cardiovascular Genetics. 2016;9(6):548-558. doi:10.1161/circgenetics.116.001485
BibTeX
@article{Jondeau2016,
author = {Jondeau, Guillaume and Ropers, Jacques and Regalado, Ellen and Braverman, Alan and Evangelista, Arturo and Teixedo, Guisela and De Backer, Julie and Muiño-Mosquera, Laura and Naudion, Sophie and Zordan, Cecile and Morisaki, Takayuki and Morisaki, Hiroto and Von Kodolitsch, Yskert and Dupuis-Girod, Sophie and Morris, Shaine A and Jeremy, Richmond and Odent, Sylvie and Adès, Leslie C and Bakshi, Madhura and Holman, Katherine and LeMaire, Scott and Milleron, Olivier and Langeois, Maud and Spentchian, Myrtille and Aubart, Melodie and Boileau, Catherine and Pyeritz, Reed and Milewicz, Dianna M and Montalcino Aortic Consortium, Montalcino Aortic Consortium},
title = {International Registry of Patients Carrying TGFBR1 or TGFBR2 Mutations},
journal = {Circulation: Cardiovascular Genetics},
year = {2016},
volume = {9},
number = {6},
pages = {548--558},
doi = {10.1161/circgenetics.116.001485}
}
EUVIMED